Abortion pill companies struggle to make sense of conflicting court rulings

  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 39 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 72%

Colombia Noticias Noticias

Colombia Últimas Noticias,Colombia Titulares

The dueling court decisions deepen the legal uncertainty for companies trying to navigate the fast-changing landscape for abortion access in the roughly nine months since the Supreme Court overturned Roe v. Wade.

one of two drugs typically used in medication abortion.

More than 250 pharmaceutical executives criticized the Texas decision in a public letter, saying it “ignores decades of scientific evidence and legal precedent” coming from a federal judge with no scientific training.“We call for the reversal of this decision to disregard science, and the appropriate restitution of the mandate for the safety and efficacy of medicines for all with the FDA, the agency entrusted to do so in the first place,” the industry leaders wrote.

Abortion on Demand, which prescribes mifepristone to patients in 23 states via a network of telehealth providers, has not adjusted any of its activities after the Texas and Washington rulings, said Leah Coplon, a nurse midwife who is director of clinical operations for the online provider.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 95. in CO
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

How evil is the GOP? They make BIG PHARMA the comparative good guys.

Welcome to anti gun laws that are unconstitutional & make law abiding citizens criminals & infringe on an actual Constitutional right.

9 months

Like the graphic on the box somehow makes it better...

Well those companies need to stand up for what they believe! It’s time to get in the game Corp America. The fact that big pharma is asking the gov to get involved is the best irony!

Colombia Últimas Noticias, Colombia Titulares